Medtronic Neurovascular Names Dr. Adam S. Arthur as Chief Medical Officer

September 24, 2025—Medtronic Neurovascular announced the appointment of Adam S. Arthur, MD, as Chief Medical Officer, effective September 30, 2025. Dr. Arthur has served as Chair of Neurosurgery at the University of Tennessee Health Science Center and is a neurosurgeon at the Semmes Murphey Clinic in Memphis, Tennessee.

Medtronic Neurovascular stated that in his new role, Dr. Arthur will guide clinical development strategy, strengthen relationships within the physician community, and further Medtronic’s commitment to continually improving patient outcomes.

Dr. Arthur will continue to devote a portion of his time to patient care through his practice at Semmes Murphey and remain on the faculty at University of Tennessee’s Health Science Center’s College of Medicine, noted the company.

“I’m excited and honored to join the team at Medtronic Neurovascular as Chief Medical Officer,” commented Dr. Arthur in the company’s press release. “My top priority is improving care for patients, and this role allows me to be closer to the innovations that will deliver better patient outcomes.”

Linnea Burman, President, Medtronic Neurovascular, added, “It’s an exciting time to be a part of the Neurovascular team as we focus on creating future breakthroughs in stroke care. I’m confident Dr. Arthur will play an important role in advancing our goal of helping more stroke patients access world-class neurovascular care.”